Beech Hill Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Beech Hill Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$812K	Sell	5,132 -28	-0.5%	-$3.79K	0.36%	72
2026 Q1	$659K	Sell	5,160 -235	-4%	-$29.3K	0.33%	71
2025 Q4	$658K	Sell	5,395 -360	-6%	-$41.3K	0.31%	71
2025 Q3	$577K	Sell	5,755 -496	-8%	-$44.7K	0.27%	75
2025 Q2	$518K	Sell	6,251 -389	-6%	-$31K	0.23%	78
2025 Q1	$539K	Sell	6,640 -15	-0.2%	-$1.34K	0.21%	80
2024 Q4	$599K	Buy	6,655 +162	+2%	+$15.7K	0.22%	78
2024 Q3	$642K	Buy	6,493 +60	+0.9%	+$5.89K	0.24%	75
2024 Q2	$596K	Sell	6,433 -35	-0.5%	-$3.14K	0.25%	74
2024 Q1	$614K	Buy	6,468 +1,616	+33%	+$150K	0.26%	69
2023 Q4	$433K	Buy	+4,852	New	+$360K	0.21%	75

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Beech Hill Advisors's XBI Position: Q2 2026 in Review

Beech Hill Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.54% in Q2 2026, selling an estimated $3.79K and leaving 5,132 shares worth $812K. The position accounts for 0.36% of the portfolio, ranked #72.

Beech Hill Advisors first reported a position in XBI in Q4 2023 and has held it in 11 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Beech Hill Advisors held 5,132 shares of State Street SPDR S&P Biotech ETF worth $812K as of Q2 2026.
Beech Hill Advisors sold 28 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $3.79K.
State Street SPDR S&P Biotech ETF made up 0.36% of Beech Hill Advisors's portfolio in Q2 2026, its #72 holding.
Beech Hill Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 11 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Beech Hill Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.